331 USD
+0.59 (+0.18%)
330.99 USD
-0.01 (0%)
AMGN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. AMGN scores excellent on profitability, but there are concerns on its financial health. AMGN is not valued too expensively and it also shows a decent growth rate. Finally AMGN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- AMGN had positive earnings in the past year.
- In the past year AMGN had a positive cash flow from operations.
- AMGN had positive earnings in each of the past 5 years.
- Each year in the past 5 years AMGN had a positive operating cash flow.
1.2 Ratios
- AMGN has a better Return On Assets (7.77%) than 93.14% of its industry peers.
- AMGN has a Return On Equity of 72.82%. This is amongst the best in the industry. AMGN outperforms 99.05% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 15.39%, AMGN belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
- AMGN had an Average Return On Invested Capital over the past 3 years of 13.04%. This is significantly below the industry average of 18.07%.
- The last Return On Invested Capital (15.39%) for AMGN is above the 3 year average (13.04%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROIC | 15.39% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
- AMGN's Profit Margin of 19.47% is amongst the best of the industry. AMGN outperforms 93.33% of its industry peers.
- In the last couple of years the Profit Margin of AMGN has declined.
- AMGN has a Operating Margin of 33.57%. This is amongst the best in the industry. AMGN outperforms 97.33% of its industry peers.
- In the last couple of years the Operating Margin of AMGN has declined.
- AMGN has a Gross Margin of 72.06%. This is amongst the best in the industry. AMGN outperforms 82.67% of its industry peers.
- AMGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMGN is creating some value.
- AMGN has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, AMGN has less shares outstanding
- AMGN has a better debt/assets ratio than last year.
2.2 Solvency
- AMGN has a debt to FCF ratio of 4.28. This is a neutral value as AMGN would need 4.28 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 4.28, AMGN belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
- A Debt/Equity ratio of 5.45 is on the high side and indicates that AMGN has dependencies on debt financing.
- AMGN's Debt to Equity ratio of 5.45 is on the low side compared to the rest of the industry. AMGN is outperformed by 80.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | N/A |
ROIC/WACC1.78
WACC8.66%
2.3 Liquidity
- A Current Ratio of 1.28 indicates that AMGN should not have too much problems paying its short term obligations.
- AMGN has a Current ratio of 1.28. This is amonst the worse of the industry: AMGN underperforms 83.05% of its industry peers.
- A Quick Ratio of 0.99 indicates that AMGN may have some problems paying its short term obligations.
- The Quick ratio of AMGN (0.99) is worse than 85.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 13.79% over the past year.
- The Earnings Per Share has been growing slightly by 5.97% on average over the past years.
- The Revenue has grown by 10.56% in the past year. This is quite good.
- The Revenue has been growing slightly by 7.43% on average over the past years.
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
3.2 Future
- AMGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.77% yearly.
- AMGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.63% yearly.
EPS Next Y9.46%
EPS Next 2Y6.31%
EPS Next 3Y5.32%
EPS Next 5Y4.77%
Revenue Next Year9.4%
Revenue Next 2Y5.49%
Revenue Next 3Y4.57%
Revenue Next 5Y3.63%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- AMGN is valuated correctly with a Price/Earnings ratio of 15.13.
- AMGN's Price/Earnings ratio is rather cheap when compared to the industry. AMGN is cheaper than 96.00% of the companies in the same industry.
- When comparing the Price/Earnings ratio of AMGN to the average of the S&P500 Index (26.94), we can say AMGN is valued slightly cheaper.
- The Price/Forward Earnings ratio is 14.78, which indicates a correct valuation of AMGN.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of AMGN indicates a rather cheap valuation: AMGN is cheaper than 95.81% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 23.94. AMGN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.13 | ||
| Fwd PE | 14.78 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AMGN is valued cheaper than 95.81% of the companies in the same industry.
- 96.95% of the companies in the same industry are more expensive than AMGN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.97 | ||
| EV/EBITDA | 12.63 |
4.3 Compensation for Growth
- AMGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- AMGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.6
PEG (5Y)2.53
EPS Next 2Y6.31%
EPS Next 3Y5.32%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.05%, AMGN has a reasonable but not impressive dividend return.
- AMGN's Dividend Yield is rather good when compared to the industry average which is at 1.18. AMGN pays more dividend than 98.86% of the companies in the same industry.
- AMGN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
5.2 History
- The dividend of AMGN is nicely growing with an annual growth rate of 9.41%!
- AMGN has paid a dividend for at least 10 years, which is a reliable track record.
- AMGN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.41%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
- 17.20% of the earnings are spent on dividend by AMGN. This is a low number and sustainable payout ratio.
- The dividend of AMGN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP17.2%
EPS Next 2Y6.31%
EPS Next 3Y5.32%
331
+0.59 (+0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners83.87%
Inst Owner Change-0.01%
Ins Owners0.06%
Ins Owner Change-0.77%
Market Cap178.24B
Revenue(TTM)35.97B
Net Income(TTM)7.00B
Analysts72.2
Price Target338.94 (2.4%)
Short Float %2.79%
Short Ratio5.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
Yearly Dividend9.01
Dividend Growth(5Y)9.41%
DP17.2%
Div Incr Years13
Div Non Decr Years13
Ex-Date02-13 2026-02-13 (2.52)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.96%
Min EPS beat(2)10.28%
Max EPS beat(2)11.64%
EPS beat(4)4
Avg EPS beat(4)9.04%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)5.13%
EPS beat(12)10
Avg EPS beat(12)4.44%
EPS beat(16)14
Avg EPS beat(16)4.21%
Revenue beat(2)2
Avg Revenue beat(2)2.59%
Min Revenue beat(2)0.68%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.17%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)1.76%
PT rev (3m)5.94%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)-7.61%
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.93%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.13 | ||
| Fwd PE | 14.78 | ||
| P/S | 4.96 | ||
| P/FCF | 13.97 | ||
| P/OCF | 13.58 | ||
| P/B | 18.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.63 |
EPS(TTM)21.87
EY6.61%
EPS(NY)22.4
Fwd EY6.77%
FCF(TTM)23.69
FCFY7.16%
OCF(TTM)24.38
OCFY7.36%
SpS66.8
BVpS17.86
TBVpS-59.79
PEG (NY)1.6
PEG (5Y)2.53
Graham Number93.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROCE | 17.67% | ||
| ROIC | 15.39% | ||
| ROICexc | 17.86% | ||
| ROICexgc | 61.56% | ||
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% | ||
| FCFM | 35.46% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score7
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.3% | ||
| Profit Quality | 182.08% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | N/A |
F-Score7
WACC8.66%
ROIC/WACC1.78
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
EPS Next Y9.46%
EPS Next 2Y6.31%
EPS Next 3Y5.32%
EPS Next 5Y4.77%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
Revenue Next Year9.4%
Revenue Next 2Y5.49%
Revenue Next 3Y4.57%
Revenue Next 5Y3.63%
EBIT growth 1Y93.73%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year42.71%
EBIT Next 3Y11.36%
EBIT Next 5Y7.69%
FCF growth 1Y36%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y24.04%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / AMGN FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to AMGN.
What is the valuation status of AMGEN INC (AMGN) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (AMGN). This can be considered as Fairly Valued.
What is the profitability of AMGN stock?
AMGEN INC (AMGN) has a profitability rating of 7 / 10.
How financially healthy is AMGEN INC?
The financial health rating of AMGEN INC (AMGN) is 3 / 10.
What is the earnings growth outlook for AMGEN INC?
The Earnings per Share (EPS) of AMGEN INC (AMGN) is expected to grow by 9.46% in the next year.